| dc.contributor.author | Lin, L. | |
| dc.contributor.author | Mehta, R. | |
| dc.contributor.author | Marcellin, P. | |
| dc.contributor.author | Ahn, S. H. | |
| dc.contributor.author | Chuang, W. -L. | |
| dc.contributor.author | Hui, A. J. | |
| dc.contributor.author | Petersen, J. | |
| dc.contributor.author | Lee, C. -M. | |
| dc.contributor.author | Ma, X. | |
| dc.contributor.author | Caruntu, F. A. | |
| dc.contributor.author | Tak, W. Y. | |
| dc.contributor.author | Elkhashab, M. | |
| dc.contributor.author | Wu, G. | |
| dc.contributor.author | Martins, E. B. | |
| dc.contributor.author | Charuworn, P. | |
| dc.contributor.author | Yee, L. J. | |
| dc.contributor.author | Lim, S. G. | |
| dc.contributor.author | Foster, G. R. | |
| dc.contributor.author | Fung, S. | |
| dc.contributor.author | Morano, L. | |
| dc.contributor.author | Samuel, D. | |
| dc.contributor.author | Agarwal, K. | |
| dc.contributor.author | Idilman, R. | |
| dc.contributor.author | Strasser, S. I. | |
| dc.contributor.author | Buti, M. | |
| dc.contributor.author | Gaeta, G. B. | |
| dc.contributor.author | Papatheodoridis, G. | |
| dc.contributor.author | Flisiak, R. | |
| dc.contributor.author | Chan, H. L. Y. | |
| dc.contributor.author | Tabak, F. | |
| dc.date.accessioned | 2021-03-06T08:35:24Z | |
| dc.date.available | 2021-03-06T08:35:24Z | |
| dc.date.issued | 2016 | |
| dc.identifier.citation | Marcellin P., Ahn S. H. , Chuang W. -. , Hui A. J. , Tabak F., Mehta R., Petersen J., Lee C. -. , Ma X., Caruntu F. A. , et al., "Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.44, ss.957-966, 2016 | |
| dc.identifier.issn | 0269-2813 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_e1b33af3-a6c2-45ff-9c14-e05444cd13d7 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/148588 | |
| dc.identifier.uri | https://doi.org/10.1111/apt.13779 | |
| dc.description.abstract | Background | |
| dc.language.iso | eng | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Temel Bilimler | |
| dc.subject | İç Hastalıkları | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | FARMAKOLOJİ VE ECZACILIK | |
| dc.subject | Farmakoloji ve Toksikoloji | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Eczacılık | |
| dc.subject | Temel Eczacılık Bilimleri | |
| dc.title | Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B | |
| dc.type | Makale | |
| dc.relation.journal | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | |
| dc.contributor.department | Liver Clin , , | |
| dc.identifier.volume | 44 | |
| dc.identifier.issue | 9 | |
| dc.identifier.startpage | 957 | |
| dc.identifier.endpage | 966 | |
| dc.contributor.firstauthorID | 236972 | |
